Article Versions Notes

Braun R, Lapshyna O, Watzelt J, Drenckhan M, Künstner A, Färber B, Hael AAM, Bolm L, Honselmann KC, Konukiewitz B, et al. Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. Cells. 2023; 12(4):587. https://doi.org/10.3390/cells12040587

Braun, Rüdiger, Olha Lapshyna, Jessica Watzelt, Maren Drenckhan, Axel Künstner, Benedikt Färber, Ahmed Ahmed Mohammed Hael, Louisa Bolm, Kim Christin Honselmann, Björn Konukiewitz, and et al. 2023. "Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response" Cells 12, no. 4: 587. https://doi.org/10.3390/cells12040587

Braun, R., Lapshyna, O., Watzelt, J., Drenckhan, M., Künstner, A., Färber, B., Hael, A. A. M., Bolm, L., Honselmann, K. C., Konukiewitz, B., Castven, D., Spielmann, M., Gorantla, S. P., Busch, H., Marquardt, J.-U., Keck, T., Wellner, U. F., & Ungefroren, H. (2023). Establishment and Molecular Characterization of Two Patient-Derived Pancreatic Ductal Adenocarcinoma Cell Lines as Preclinical Models for Treatment Response. Cells, 12(4), 587. https://doi.org/10.3390/cells12040587